{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:34:18Z","timestamp":1792697658813,"version":"4.5.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Congenital hyperinsulinism (HI) is a rare disease that causes severe hypoglycemia. Diazoxide is the first-line treatment; however, many individuals using diazoxide continue to experience hypoglycemia. Diazoxide is associated with side effects that impact life and well-being.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study utilized a mixed-methods approach combining structured, survey-based cross-sectional quantitative data from the HI Global Registry (HIGR) (n=165, 89% were caregivers), of whom 75% reported current diazoxide use, with qualitative interviews with caregivers (n=12) and individuals with HI (n=6). This is the first mixed-methods study to focus on the experience of diazoxide treatment as reported by the individual taking the medicine and\/or their caregiver.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of HIGR participants, 93% reported at least one side effect, including hypertrichosis (89%), loss of appetite (40%), facial changes (23%), and swelling (22%) with diazoxide use. In HIGR, 37% of people currently on diazoxide reported experiencing hypoglycemia up to several times per week. Interview participants described how these side effects, the drug\u2019s taste, and feeding difficulties associated with HI and diazoxide adversely impacted daily life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Diazoxide is commonly used by families living with HI, but a significant proportion reported hypoglycemia. Individuals who experienced better glycemic control with the drug were less critical of side effects. Combining HIGR data with in-depth interviews facilitated understanding of day-to-day life, which can help implement measures to better support families managing HI. This study prompts the need for improved treatment options and for clinicians to utilize the International HI Care Guideline to optimize diazoxide therapy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1628125","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T15:58:32Z","timestamp":1755791912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Real-world experience with the use of diazoxide among people living with congenital hyperinsulinism and their caregivers"],"prefix":"10.3389","volume":"16","author":[{"given":"Tai L. S.","family":"Pasquini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen E.","family":"Rohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona J.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indraneel","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Dastamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diva D.","family":"De Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren N.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228417","article-title":"Using referral rates for genetic testing to determine the incidence of a rare disease: The minimal incidence of congenital hyperinsulinism in the UK is 1 in 28,389","volume":"15","author":"Yau","year":"2020","journal-title":"PloS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000539464","article-title":"The birth prevalence of congenital hyperinsulinism: A narrative review of the epidemiology of a rare disease","author":"Lapidus","year":"2024","journal-title":"Horm Res Paediatr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2539","article-title":"High risk of diabetes and neurobehavioral deficits in individuals with surgically treated hyperinsulinism","volume":"100","author":"Lord","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000481774","article-title":"Formal neurocognitive testing in 60 patients with congenital hyperinsulinism","volume":"89","author":"Ludwig","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-63","article-title":"Congenital hyperinsulinism: current trends in diagnosis and therapy","volume":"6","author":"Arnoux","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.876903","article-title":"Global registries in congenital hyperinsulinism","volume":"13","author":"Pasquini","year":"2022","journal-title":"Front Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12548","article-title":"Diagnosis of congenital hyperinsulinism: Biochemical profiles during hypoglycemia","volume":"19","author":"Sakakibara","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1159\/000531766","article-title":"International guidelines for the diagnosis and management of hyperinsulinism","volume":"97","author":"De Leon","year":"2024","journal-title":"Horm Res Paediatr"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-024-3211-3","article-title":"Congenital hyperinsulinism - notes for the general pediatrician","volume":"61","author":"Estebanez","year":"2024","journal-title":"Indian Pediatr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3651","article-title":"Perspective on the genetics and diagnosis of congenital hyperinsulinism disorders","volume":"101","author":"Stanley","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25495","article-title":"ATP-sensitive potassium channelopathies: focus on insulin secretion","volume":"115","author":"Ashcroft","year":"2005","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2169","article-title":"Genotype and phenotype correlations in 417 children with congenital hyperinsulinism","volume":"98","author":"Snider","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246463","article-title":"Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: A systematic review and meta-analysis","volume":"16","author":"Chen","year":"2021","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000526442","article-title":"Congenital hyperinsulinism: an historical perspective","volume":"95","author":"Thornton","year":"2022","journal-title":"Horm Res Paediatr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.545638","article-title":"Possible new strategies for the treatment of congenital hyperinsulinism","volume":"11","author":"Sikimic","year":"2020","journal-title":"Front Endocrinol"},{"key":"B16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-030-02961-6_2","article-title":"Diazoxide-responsive forms of congenital hyperinsulinism","volume-title":"Congenital Hyperinsulinism: A Practical Guide to Diagnosis and Management","author":"Yau","year":"2019"},{"key":"B17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1530\/EDM-18-0120","article-title":"Shah P. Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutation","volume":"2019","author":"Kiff","year":"2019","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13023-022-02214-y","article-title":"Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families","volume":"17","author":"Banerjee","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa543","article-title":"Management and appropriate use of diazoxide in infants and children with hyperinsulinism","volume":"105","author":"Brar","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/11795476231151330","article-title":"Diazoxide-induced hypertrichosis in a neonate with transient hyperinsulinism","volume":"16","author":"Boskabadi","year":"2023","journal-title":"Clin Med Insights Case Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000497458","article-title":"Rate of serious adverse events associated with diazoxide treatment of patients with hyperinsulinism","volume":"91","author":"Thornton","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/children10010005","article-title":"Diazoxide for neonatal hyperinsulinemic hypoglycemia and pulmonary hypertension","volume":"10","author":"Newman-Lindsay","year":"2022","journal-title":"Child Basel Switz"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.10463","article-title":"Facial appearance in persistent hyperinsulinemic hypoglycemia","volume":"111","author":"de Lonlay","year":"2002","journal-title":"Am J Med Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01613","article-title":"Prevalence of adverse events in children with congenital hyperinsulinism treated with diazoxide","volume":"103","author":"Herrera","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/dme.13823","article-title":"Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia","volume":"36","author":"Banerjee","year":"2019","journal-title":"Diabetes Med J Br Diabetes Assoc"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-017-1652-3","article-title":"Development of pulmonary hypertension during treatment with diazoxide: A case series and literature review","volume":"38","author":"Timlin","year":"2017","journal-title":"Pediatr Cardiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14096","article-title":"Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom","volume":"91","author":"Chen","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5863\/1551-6776-18.3.199","article-title":"Management strategies for neonatal hypoglycemia","volume":"18","author":"Sweet","year":"2013","journal-title":"J Pediatr Pharmacol Ther JPPT"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/adc.64.10.1496","article-title":"Complications of diazoxide treatment in persistent neonatal hyperinsulinism","volume":"64","author":"Abu-Osba","year":"1989","journal-title":"Arch Dis Child"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2021.383","article-title":"Diazoxide-induced neutropenia and long-term follow-up in a patient with hyperinsulinemia-hyperammonemia due to GLUD1 mutation","volume":"17","author":"Vuralli","year":"2021","journal-title":"Acta Endocrinol Buchar Rom 2005"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.7336","article-title":"Congenital hyperinsulinemic hypoglycemia (HH) requiring treatment as the presenting feature of Kabuki syndrome","volume":"11","author":"Souabni","year":"2023","journal-title":"Clin Case Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.886552","article-title":"Congenital hyperinsulinism international: A community focused on improving the lives of people living with congenital hyperinsulinism","volume":"13","author":"Raskin","year":"2022","journal-title":"Front Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2012-0224","article-title":"The treatment effect of diazoxide on 44 patients with congenital hyperinsulinism","volume":"25","author":"Hu","year":"2012","journal-title":"J Pediatr Endocrinol Metab JPEM"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2020-319057","article-title":"Necrotising enterocolitis in newborns receiving diazoxide","volume":"106","author":"Prado","year":"2021","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.epsc.2019.101356","article-title":"Necrotizing enterocolitis following diazoxide therapy for persistent neonatal hypoglycemia","volume":"52","author":"Theodorou","year":"2020","journal-title":"J Pediatr Surg Case Rep"},{"key":"B36","article-title":"Assessing global access to treatments and care for people living with hyperinsulinism","author":"Raskin","year":"2020"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Med Care"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-3-70","article-title":"The European DISABKIDS project: development of seven condition-specific modules to measure health related quality of life in children and adolescents","volume":"3","author":"Baars","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"B39","first-page":"220 p","volume-title":"Researching Lived Experience: Human Science for an Action Sensitive Pedagogy","author":"van Manen","year":"2016"},{"key":"B40","first-page":"228 p","volume-title":"Constructing Grounded Theory: A Practical Guide Through Qualitative Analysis","author":"Charmaz","year":"2006"},{"key":"B41","doi-asserted-by":"crossref","first-page":"379 p","DOI":"10.4135\/9781452230153","volume-title":"Basics of qualitative research: Techniques and procedures for developing grounded theory","author":"Corbin","year":"2008"},{"key":"B42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13023-018-0867-6","article-title":"The burden of congenital hyperinsulinism in the United Kingdom: a cost of illness study","volume":"13","author":"Eljamel","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-022-02299-5","article-title":"The national economic burden of rare disease in the United States in 2019","volume":"17","author":"Yang","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B44","volume-title":"HI Global Registry Annual Report","author":"Lopez","year":"2024"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00091","article-title":"Determinants of patient adherence: a review of systematic reviews","volume":"4","author":"Kardas","year":"2013","journal-title":"Front Pharmacol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13023-015-0367-x","article-title":"Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers","volume":"10","author":"Welters","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1186\/s12905-023-02798-y","article-title":"The health of mothers caring for a child with a disability: a longitudinal study","volume":"23","author":"Brekke","year":"2023","journal-title":"BMC Womens Health"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/01612840600840588","article-title":"Mental health of mothers caring for ventilator-assisted children at home","volume":"27","author":"Kuster","year":"2006","journal-title":"Issues Ment Health Nurs"},{"key":"B49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijnurstu.2006.08.007","article-title":"The impact on mothers of bringing up a child with intellectual disabilities: a cross-cultural study","volume":"45","author":"McConkey","year":"2008","journal-title":"Int J Nurs Stud"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.16.1749","article-title":"Impact of a child\u2019s chronic illness on maternal sleep and daytime functioning","volume":"166","author":"Meltzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/cch.12628","article-title":"It is like a jungle gym, and everything is under construction\u201d: The parent\u2019s perspective of caring for a child with a rare disease","volume":"45","author":"Currie","year":"2019","journal-title":"Child Care Health Dev"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-018-0294-9","article-title":"Alone in a crowd? Parents of children with rare diseases\u2019 Experiences of navigating the healthcare system","volume":"28","author":"Baumbusch","year":"2018","journal-title":"J Genet Couns"},{"key":"B53","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s13023-021-01943-w","article-title":"Navigating the U.S. health insurance landscape for children with rare diseases: a qualitative study of parents\u2019 experiences","volume":"16","author":"Pasquini","year":"2021","journal-title":"Orphanet J Rare Dis"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1628125\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T15:58:33Z","timestamp":1755791913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1628125\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":53,"alternative-id":["10.3389\/fendo.2025.1628125"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1628125","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"article-number":"1628125"}}